Plasma Matrix Metalloproteinase Concentrations and Risk of Interstitial Lung Disease in a Prospective Rheumatoid Arthritis Cohort,Arthritis & Rheumatology

当前位置： X-MOL 学术 › Arthritis Rheumatol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Plasma Matrix Metalloproteinase Concentrations and Risk of Interstitial Lung Disease in a Prospective Rheumatoid Arthritis Cohort
Arthritis & Rheumatology ( IF 13.3 ) Pub Date : 2024-01-25 , DOI: 10.1002/art.42812
Brent A. Luedders _{1,

2} , Austin M. Wheeler _{1,

2} , Dana P. Ascherman ₃ , Joshua F. Baker ₄ , Michael J. Duryee _{1,

2} , Yangyuna Yang _{1,

2} , Punyasha Roul _{1,

2} , Katherine D. Wysham ₅ , Paul Monach ₆ , Andreas Reimold ₇ , Gail S. Kerr ₈ , Gary Kunkel ₉ , Grant W. Cannon ₉ , Jill A. Poole ₂ , Geoffrey M. Thiele _{1,

2} , Ted R. Mikuls _{1,

2} , Bryant R. England _{1,

2}

Affiliation

To evaluate the associations of plasma matrix metalloproteinases (MMPs) with prevalent and incident interstitial lung disease (ILD) in people with rheumatoid arthritis (RA).

中文翻译：